NCT07164755View on ClinicalTrials.gov

Measurement of Serum Inflammatory Markers in Patients Treatment-resistant Depression Given Psilocybin

Active, not recruitingOBSERVATIONAL

Enrollment

46

Participants

Timeline

Start Date

June 21, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Depression - Major Depressive Disorder

Trial Locations (1)

SE5 8AF

King's College London Institute of Psychiatry, Psychology and Neuroscience, London

All Listed Sponsors

lead

King's College London

OTHER